Some functions of this side are available with javascript only!
Emory University
Explore the Research Trends
Explore the Research Network
This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is a combination of Scopus and researcher data.
1.
M.C. Lowe; I.R. Badell; A.P. Turner; P.W. Thompson; F.V. Leopardi; E.A. Strobert; C.P. Larsen; A.D. Kirk
Belatacept and sirolimus prolong nonhuman primate islet allograft survival: Adverse consequences of concomitant alefacept therapy
2.
D.J. Lo; D.J. Anderson; T.A. Weaver; F. Leopardi; M. Song; A.B. Farris; E.A. Strobert; J. Jenkins; N.A. Turgeon; A.K. Mehta; et al.
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion
3.
A.D. Kirk
The cam-path forward
4.
M. Lowe; I.R. Badell; P. Thompson; B. Martin; F. Leopardi; E. Strobert; A.A. Price; H.S. Abdulkerim; R. Wang; N.N. Iwakoshi; et al.
A novel monoclonal antibody to CD40 prolongs islet allograft survival
5.
P. Thompson; I.R. Badell; M. Lowe; A. Turner; J. Cano; J. Avila; A. Azimzadeh; X. Cheng; R.N. Pierson III; B. Johnson; et al.
Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival
6.
Wai-Johnn Sam; Christine E. Chamberlain; Su-Jun Lee; Joyce A. Goldstein; Douglas A. Hale; Roslyn B. Mannon; Allan D. Kirk; Yuen Yi Hon
Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients
7.
A. Page; S. Srinivasan; K. Singh; M. Russell; K. Hamby; T. Deane; S. Sen; L. Stempora; F. Leopardi; A.A. Price; et al.
CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model
8.
I.R. Badell; M.C. Russell; K. Cardona; V.O. Shaffer; A.P. Turner; J.G. Avila; J.A. Cano; F.V. Leopardi; M. Song; E.A. Strobert; et al.
CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8
9.
D.C. Neujahr; S.D. Perez; A. Mohammed; O. Ulukpo; E.C. Lawrence; F. Fernandez; A. Pickens; S.D. Force; M. Song; C.P. Larsen; et al.
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant
10.
S.K. Ramakrishnan; A. Page; A.B. Farris III; K. Singh; F. Leopardi; K. Hamby; S. Sen; A. Polnett; T. Deane; M. Song; et al.
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques
11.
Victoria M. Velazquez; Huiming Hon; Chris Ibegbu; Stuart J. Knechtle; Allan D. Kirk; Arash Grakoui
Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection
12.
W.H. Kitchens; D. Haridas; M.E. Wagener; M. Song; A.D. Kirk; C.P. Larsen; M.L. Ford
Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8 + memory T cells
13.
I.R. Badell; P.W. Thompson; A.P. Turner; M.C. Russell; J.G. Avila; J.A. Cano; J.M. Robertson; F.V. Leopardi; E.A. Strobert; N.N. Iwakoshi; et al.
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates
14.
J. Kwun; B.C. Oh; A.C. Gibby; R. Ruhil; V.T. Lu; D.W. Kim; E.K. Page; O.P. Bulut; M.Q. Song; A.B. Farris; et al.
Patterns of de Novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment
15.
A.H. Charafeddine; E.J. Kim; D.M. Maynard; H. Yi; T.A. Weaver; M. Gunay-Aygun; M. Russell; W.A. Gahl; A.D. Kirk
Platelet-derived CD154: Ultrastructural localization and clinical correlation in organ transplantation
16.
K. Singh; N. Kozyr; L. Stempora; A.D. Kirk; C.P. Larsen; B.R. Blazar; L.S. Kean
Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus
17.
Nitika A. Gupta; Vasantha L. Kolachala; Rong Jiang; Carlos Abramowsky; Rene Romero; Nimita Fifadara; Frank Anania; Stuart Knechtle; Allan Kirk
The glucagon-like peptide-1 receptor agonist exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis
18.
Nicole A. Turgeon; Sebastian Perez; Max Mondestin; S. Scott Davis; Edward Lin; Sudha Tata; Allan D. Kirk; Christian P. Larsen; Thomas C. Pearson; John F. Sweene
The impact of renal function on outcomes of bariatric surgery
19.
Ivana R. Ferrer; Maylene E. Wagener; Minqing Song; Allan D. Kirk; Christian P. Larsen; Mandy L. Ford
Antigen-specific induced Foxp3 + regulatory T cells are generated following CD40/CD154 blockade
20.
Associations of ABCB1 3435C>T and IL-10 -1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients